Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Oshita

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1994
[The present status and prospects for clinical oncology in Japan]F Oshita, N Saijo
Oncology Research|January 1, 1993
Gene-specific damage produced by cisplatin, ormaplatin and UV light in human cells as assayed by the polymerase chain reactionF Oshita, A Eastman
Japanese Journal of Cancer Research : Gann|July 1, 1994
Rapid polymerase chain reaction assay to detect variation in the extent of gene-specific damage between cisplatin- or VP-16-resistant and sensitive lung cancer cell linesF Oshita, N Saijo
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Radiation sensitivities in various anticancer-drug-resistant human lung cancer cell lines and mechanism of radiation cross-resistance in a cisplatin-resistant cell lineF Oshita, Y Fujiwara, N Saijo
Anticancer Research|December 22, 1998
Gene-specific damage produced by topoisomerase inhibitors in human lung cancer cells and peripheral mononuclear cells as assayed by polymerase chain reaction-stop assayF Oshita, K Yamada, I Nomura, et al.
Japanese Journal of Cancer Research : Gann|February 1, 1995
Correlation of gene-specific damage with cisplatin between human adenocarcinoma cells and peripheral blood mononuclear cells analyzed by polymerase chain reaction-stop assayF Oshita, H Arioka, Y Heike, et al.
American Journal of Clinical Oncology|February 20, 1999
Early monocytopenia after chemotherapy as a risk factor for neutropeniaM Kondo, F Oshita, Y Kato, et al.
American Journal of Clinical Oncology|June 17, 2000
Prophylactic administration of granulocyte colony-stimulating factor when monocytopenia appears lessens neutropenia caused by chemotherapy for lung cancerF Oshita, K Yamada, I Nomura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Detection of K-ras mutations of bronchoalveolar lavage fluid cells aids the diagnosis of lung cancer in small pulmonary lesionsF Oshita, I Nomura, K Yamada, et al.
Oncology Reports|June 19, 2001
Randomized study of dose or schedule modification of granulocyte colony-stimulating factor in platinum-based chemotherapy for elderly patients with lung cancerF Oshita, K Yamada, I Nomura, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1994
[The present status and prospects for clinical oncology in Japan]F Oshita, N Saijo
Oncology Research|January 1, 1993
Gene-specific damage produced by cisplatin, ormaplatin and UV light in human cells as assayed by the polymerase chain reactionF Oshita, A Eastman
Japanese Journal of Cancer Research : Gann|July 1, 1994
Rapid polymerase chain reaction assay to detect variation in the extent of gene-specific damage between cisplatin- or VP-16-resistant and sensitive lung cancer cell linesF Oshita, N Saijo
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Radiation sensitivities in various anticancer-drug-resistant human lung cancer cell lines and mechanism of radiation cross-resistance in a cisplatin-resistant cell lineF Oshita, Y Fujiwara, N Saijo
Anticancer Research|December 22, 1998
Gene-specific damage produced by topoisomerase inhibitors in human lung cancer cells and peripheral mononuclear cells as assayed by polymerase chain reaction-stop assayF Oshita, K Yamada, I Nomura, et al.
Japanese Journal of Cancer Research : Gann|February 1, 1995
Correlation of gene-specific damage with cisplatin between human adenocarcinoma cells and peripheral blood mononuclear cells analyzed by polymerase chain reaction-stop assayF Oshita, H Arioka, Y Heike, et al.
American Journal of Clinical Oncology|February 20, 1999
Early monocytopenia after chemotherapy as a risk factor for neutropeniaM Kondo, F Oshita, Y Kato, et al.
American Journal of Clinical Oncology|June 17, 2000
Prophylactic administration of granulocyte colony-stimulating factor when monocytopenia appears lessens neutropenia caused by chemotherapy for lung cancerF Oshita, K Yamada, I Nomura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Detection of K-ras mutations of bronchoalveolar lavage fluid cells aids the diagnosis of lung cancer in small pulmonary lesionsF Oshita, I Nomura, K Yamada, et al.
Oncology Reports|June 19, 2001
Randomized study of dose or schedule modification of granulocyte colony-stimulating factor in platinum-based chemotherapy for elderly patients with lung cancerF Oshita, K Yamada, I Nomura, et al.
Pageof 5